Skip to content
Contact
0
IDKmonitor Rituximab drug level assay
Back To Our Shop

Rituximab Drug Level ELISA (IDKmonitor®)

The IDKmonitor Rituximab Drug Level ELISA kit is a microplate-based quantitative assay for the determination of free rituximab from plasma or serum samples. Rituximab is a chimeric therapeutic monoclonal antibody (mAb) that targets B-cells (CD-20) in the treatment of rheumatoid arthritis, non-Hodgkin’s B-cell lymphomas, lymphocytic leukaemia, active granulomatosis with polyangiitis and microscopic polyangiitis.

Categories:,
Download Brochure Technical Support Request a Quote

Key Advantages

Highly specific quantification of rituximab in serum and plasma

Quick and reliable, with a total incubation time of 130 minutes

Applicable to rheumatology

Reportable range 5.08-500 ug/ml

Easily automated on ELISA automates, such as the Dynex DS2

Unboxing of Peptest

Interested in this product? Get in touch

Our team of experts are on hand to answer any questions you may have about this product, or any of our other offerings.
  • Product code: Product code: K9661 (96 wells)

Determination of free therapeutic rituximab

The IDKmonitor Rituximab Drug Level ELISA kit is a microplate-based quantitative assay for the determination of free rituximab from plasma or serum samples. Rituximab is a chimeric therapeutic monoclonal antibody (mAb) that targets B-cells (CD-20) in the treatment of rheumatoid arthritis, non-Hodgkin’s B-cell lymphomas, lymphocytic leukaemia, active granulomatosis with polyangiitis and microscopic polyangiitis.

  • ELISA

  • 40 tests

  • Storage: 2-8 °C

  • Blood sample